We generate selective compounds leveraging
our proprietary G-SMART™ platform
Our Science
* 각 영역 이미지 클릭 시, 원본 이미지를 보실 수 있습니다.
GENO-K is an innovative platform designed by Genosco Inc. to accelerate the development of kinase inhibitors. Kinases are crucial enzymes that regulate cell growth, survival, metabolism, and more. While there are approximately 518 kinases present in humans, only a fraction of them have been utilized for drug development. The GENO-K platform aims to efficiently explore these kinases to expand therapeutic possibilities.
GENO-K utilizes a comprehensive protein database (GENO-K PDB) and a specialized compound library (GENO-K LDB) to develop highly selective inhibitors that target specific kinases. Through this approach, GENO-K is working to develop treatments for various diseases, including lung cancer, autoimmune diseases, and idiopathic pulmonary fibrosis.
